Keywords
Last Name
Institution

GLENN R CUNNINGHAM

TitleDistinguished Emeritus Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
DivisionMedicine-Endocrinology
AddressOne Baylor Plaza
Houston TX 77030
vCardDownload vCard
    Other Positions
    TitleDistinguished Emeritus Professor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Molecular & Cellular Biology
    DivisionMolecular & Cellular Biology


    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Rosen RC, Wu F, Behre HM, Porst H, Meuleman EJH, Maggi M, Romero-Otero J, Martinez-Salamanca JI, Jones TH, Debruyne FMJ, Kurth KH, Hackett GI, Quinton R, Stroberg P, Reisman Y, Pescatori ES, Morales A, Bassas L, Cruz N, Cunningham GR, Wheaton OA. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME). J Sex Med. 2017 Aug 03. PMID: 28781213.
      View in: PubMed
    2. Cunningham G, Belkoff L, Brock G, Efros M, Gittelman M, Carrara D, Neijber A, Ando M, Mitchel J. EFFICACY AND SAFETY OF A NEW TOPICAL TESTOSTERONE REPLACEMENT GEL THERAPY FOR THE TREATMENT OF MALE HYPOGONADISM. Endocr Pract. 2017 Feb 22. PMID: 28225313.
      View in: PubMed
    3. Snyder PJ, Kopperdahl DL, Stephens-Shields AJ, Ellenberg SS, Cauley JA, Ensrud KE, Lewis CE, Barrett-Connor E, Schwartz AV, Lee DC, Bhasin S, Cunningham GR, Gill TM, Matsumoto AM, Swerdloff RS, Basaria S, Diem SJ, Wang C, Hou X, Cifelli D, Dougar D, Zeldow B, Bauer DC, Keaveny TM. Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial. JAMA Intern Med. 2017 Feb 21. PMID: 28241231.
      View in: PubMed
    4. Roy CN, Snyder PJ, Stephens-Shields AJ, Artz AS, Bhasin S, Cohen HJ, Farrar JT, Gill TM, Zeldow B, Cella D, Barrett-Connor E, Cauley JA, Crandall JP, Cunningham GR, Ensrud KE, Lewis CE, Matsumoto AM, Molitch ME, Pahor M, Swerdloff RS, Cifelli D, Hou X, Resnick SM, Walston JD, Anton S, Basaria S, Diem SJ, Wang C, Schrier SL, Ellenberg SS. Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial. JAMA Intern Med. 2017 Feb 21. PMID: 28241237.
      View in: PubMed
    5. Resnick SM, Matsumoto AM, Stephens-Shields AJ, Ellenberg SS, Gill TM, Shumaker SA, Pleasants DD, Barrett-Connor E, Bhasin S, Cauley JA, Cella D, Crandall JP, Cunningham GR, Ensrud KE, Farrar JT, Lewis CE, Molitch ME, Pahor M, Swerdloff RS, Cifelli D, Anton S, Basaria S, Diem SJ, Wang C, Hou X, Snyder PJ. Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment. JAMA. 2017 02 21; 317(7):717-727. PMID: 28241356.
      View in: PubMed
    6. Budoff MJ, Ellenberg SS, Lewis CE, Mohler ER, Wenger NK, Bhasin S, Barrett-Connor E, Swerdloff RS, Stephens-Shields A, Cauley JA, Crandall JP, Cunningham GR, Ensrud KE, Gill TM, Matsumoto AM, Molitch ME, Nakanishi R, Nezarat N, Matsumoto S, Hou X, Basaria S, Diem SJ, Wang C, Cifelli D, Snyder PJ. Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone. JAMA. 2017 02 21; 317(7):708-716. PMID: 28241355.
      View in: PubMed
    7. Maggi M, Wu FC, Jones TH, Jackson G, Behre HM, Hackett G, Martin-Morales A, Balercia G, Dobs AS, Arver ST, Maggio M, Cunningham GR, Isidori AM, Quinton R, Wheaton OA, Siami FS, Rosen RC. Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME). Int J Clin Pract. 2016 Oct; 70(10):843-852. PMID: 27774779.
      View in: PubMed
    8. Cunningham GR, Stephens-Shields AJ, Rosen RC, Wang C, Bhasin S, Matsumoto AM, Parsons JK, Gill TM, Molitch ME, Farrar JT, Cella D, Barrett-Connor E, Cauley JA, Cifelli D, Crandall JP, Ensrud KE, Gallagher L, Zeldow B, Lewis CE, Pahor M, Swerdloff RS, Hou X, Anton S, Basaria S, Diem SJ, Tabatabaie V, Ellenberg SS, Snyder PJ. Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels. J Clin Endocrinol Metab. 2016 Aug; 101(8):3096-104. PMID: 27355400; PMCID: PMC4971331 [Available on 08/01/17].
    9. Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM, Barrett-Connor E, Swerdloff RS, Wang C, Ensrud KE, Lewis CE, Farrar JT, Cella D, Rosen RC, Pahor M, Crandall JP, Molitch ME, Cifelli D, Dougar D, Fluharty L, Resnick SM, Storer TW, Anton S, Basaria S, Diem SJ, Hou X, Mohler ER, Parsons JK, Wenger NK, Zeldow B, Landis JR, Ellenberg SS. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016 Feb 18; 374(7):611-24. PMID: 26886521.
      View in: PubMed
    10. Rosen RC, Stephens-Shields AJ, Cunningham GR, Cifelli D, Cella D, Farrar JT, Barrett-Connor E, Lewis CE, Pahor M, Hou X, Snyder PJ. Comparison of interactive voice response (IVR) with paper administration of instruments to assess functional status, sexual function, and quality of life in elderly men. Qual Life Res. 2016 Apr; 25(4):811-21. PMID: 26358063; PMCID: PMC4786466.
    11. Goodman N, Guay A, Dandona P, Dhindsa S, Faiman C, Cunningham GR. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF TESTOSTERONE AND CARDIOVASCULAR RISK. Endocr Pract. 2015 Sep; 21(9):1066-73. PMID: 26355962.
      View in: PubMed
    12. Cauley JA, Fluharty L, Ellenberg SS, Gill TM, Ensrud KE, Barrett-Connor E, Cifelli D, Cunningham GR, Matsumoto AM, Bhasin S, Pahor M, Farrar JT, Cella D, Rosen RC, Resnick SM, Swerdloff RS, Lewis CE, Molitch ME, Crandall JP, Stephens-Shields AJ, Strorer TW, Wang C, Anton S, Basaria S, Diem S, Tabatabaie V, Dougar D, Hou X, Snyder PJ. Recruitment and Screening for the Testosterone Trials. J Gerontol A Biol Sci Med Sci. 2015 Sep; 70(9):1105-11. PMID: 25878029.
      View in: PubMed
    13. Cunningham GR. Testosterone and metabolic syndrome. Asian J Androl. 2015 Mar-Apr; 17(2):192-6. PMID: 25652634; PMCID: PMC4650473.
    14. Cunningham GR, Stephens-Shields AJ, Rosen RC, Wang C, Ellenberg SS, Matsumoto AM, Bhasin S, Molitch ME, Farrar JT, Cella D, Barrett-Connor E, Cauley JA, Cifelli D, Crandall JP, Ensrud KE, Fluharty L, Gill TM, Lewis CE, Pahor M, Resnick SM, Storer TW, Swerdloff RS, Anton S, Basaria S, Diem S, Tabatabaie V, Hou X, Snyder PJ. Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials. J Clin Endocrinol Metab. 2015 Mar; 100(3):1146-55. PMID: 25548978; PMCID: PMC4333035.
    15. Shawa H, Bajaj M, Cunningham GR. Pheochromocytoma-induced atrial tachycardia leading to cardiogenic shock and cardiac arrest: resolution with atrioventricular node ablation and pacemaker placement. Tex Heart Inst J. 2014 Dec; 41(6):660-3. PMID: 25593537; PMCID: PMC4251344.
    16. Snyder PJ, Ellenberg SS, Cunningham GR, Matsumoto AM, Bhasin S, Barrett-Connor E, Gill TM, Farrar JT, Cella D, Rosen RC, Resnick SM, Swerdloff RS, Cauley JA, Cifelli D, Fluharty L, Pahor M, Ensrud KE, Lewis CE, Molitch ME, Crandall JP, Wang C, Budoff MJ, Wenger NK, Mohler ER, Bild DE, Cook NL, Keaveny TM, Kopperdahl DL, Lee D, Schwartz AV, Storer TW, Ershler WB, Roy CN, Raffel LJ, Romashkan S, Hadley E. The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials. 2014 Jun; 11(3):362-375. PMID: 24686158.
      View in: PubMed
    17. Mathur S, Boparai J, Mediwala SN, Garcia JM, Cunningham GR, Marcelli M, Vasudevan MM. Reversible Adrenal Insufficiency in Three Patients With Post-Roux-en-Y Gastric Bypass Noninsulinoma Pancreatogenous Hypoglycemia Syndrome. J Investig Med High Impact Case Rep. 2014 Jan-Mar; 2(1):2324709614526992. PMID: 26425596.
      View in: PubMed
    18. Miner M, Nehra A, Jackson G, Bhasin S, Billups K, Burnett AL, Buvat J, Carson C, Cunningham G, Ganz P, Goldstein I, Guay A, Hackett G, Kloner RA, Kostis JB, LaFlamme KE, Montorsi P, Ramsey M, Rosen R, Sadovsky R, Seftel A, Shabsigh R, Vlachopoulos C, Wu F. All men with vasculogenic erectile dysfunction require a cardiovascular workup. Am J Med. 2014 Mar; 127(3):174-82. PMID: 24423973.
      View in: PubMed
    19. Cunningham GR, Daoud D, Baimbridge S, Baimbridge C, Abdelnour S. Effects of glycemia on immediate complications following CABG. Endocr Pract. 2013 Nov-Dec; 19(6):928-36. PMID: 23807516.
      View in: PubMed
    20. Cunningham GR. Andropause or male menopause? Rationale for testosterone replacement therapy in older men with low testosterone levels. Endocr Pract. 2013 Sep-Oct; 19(5):847-52. PMID: 24014001.
      View in: PubMed
    21. Wiehle R, Cunningham GR, Pitteloud N, Wike J, Hsu K, Fontenot GK, Rosner M, Dwyer A, Podolski J. Testosterone Restoration by Enclomiphene Citrate in Men with Secondary Hypogonadism: Pharmacodynamics and Pharmacokinetics. BJU Int. 2013 Jul 12. PMID: 23875626.
      View in: PubMed
    22. Jackson G, Nehra A, Miner M, Billups KL, Burnett AL, Buvat J, Carson CC, Cunningham G, Goldstein I, Guay AT, Hackett G, Kloner RA, Kostis JB, Montorsi P, Ramsey M, Rosen R, Sadovsky R, Seftel AD, Shabsigh R, Vlachopoulos C, Wu FC. The assessment of vascular risk in men with erectile dysfunction: the role of the cardiologist and general physician. Int J Clin Pract. 2013 Nov; 67(11):1163-72. PMID: 23714173.
      View in: PubMed
    23. Nehra A, Jackson G, Miner M, Billups KL, Burnett AL, Buvat J, Carson CC, Cunningham GR, Goldstein I, Guay AT, Hackett G, Kloner RA, Kostis J, Montorsi P, Ramsey M, Rosen RC, Sadovsky R, Seftel AD, Vlachopoulos C, Wu FC. Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk. J Urol. 2013 Jun; 189(6):2031-8. PMID: 23313195.
      View in: PubMed
    24. Cunningham GR. Diabetes and cardiovascular disease: what have we learned in 2012? Tex Heart Inst J. 2013; 40(3):290-2. PMID: 23914022; PMCID: PMC3709222.
    25. Nehra A, Jackson G, Miner M, Billups KL, Burnett AL, Buvat J, Carson CC, Cunningham GR, Ganz P, Goldstein I, Guay AT, Hackett G, Kloner RA, Kostis J, Montorsi P, Ramsey M, Rosen R, Sadovsky R, Seftel AD, Shabsigh R, Vlachopoulos C, Wu FC. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012 Aug; 87(8):766-78. PMID: 22862865; PMCID: PMC3498391.
    26. Wang C, Jackson G, Jones TH, Matsumoto AM, Nehra A, Perelman MA, Swerdloff RS, Traish A, Zitzmann M, Cunningham G. Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care. 2011 Jul; 34(7):1669-75. PMID: 21709300; PMCID: PMC3120209.
    27. Cunningham GR, Toma SM. Clinical review: Why is androgen replacement in males controversial? J Clin Endocrinol Metab. 2011 Jan; 96(1):38-52. PMID: 20881265.
      View in: PubMed
    28. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010 Jun; 95(6):2536-59. PMID: 20525905.
      View in: PubMed
    29. Beg S, Al-Khoury L, Cunningham GR. Testosterone replacement in men. Curr Opin Endocrinol Diabetes Obes. 2008 Aug; 15(4):364-70. PMID: 18594278.
      View in: PubMed
    30. Shao TC, Li H, Ittmann M, Cunningham GR. Effects of dutasteride on prostate growth in the large probasin-large T antigen mouse model of prostate cancer. J Urol. 2007 Oct; 178(4 Pt 1):1521-7. PMID: 17707058.
      View in: PubMed
    31. Garcia JM, Li H, Mann D, Epner D, Hayes TG, Marcelli M, Cunningham GR. Hypogonadism in male patients with cancer. Cancer. 2006 Jun 15; 106(12):2583-91. PMID: 16688773.
      View in: PubMed
    32. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2006 Jun; 91(6):1995-2010. PMID: 16720669.
      View in: PubMed
    33. Cunningham GR. Testosterone replacement therapy for late-onset hypogonadism. Nat Clin Pract Urol. 2006 May; 3(5):260-7. PMID: 16691239.
      View in: PubMed
    34. Shao TC, Li HL, Kasper S, Matusik R, Ittmann M, Cunningham GR. Comparison of the growth-promoting effects of testosterone and 7-alpha-methyl-19-nor-testosterone (MENT) on the prostate and levator ani muscle of LPB-tag transgenic mice. Prostate. 2006 Mar 1; 66(4):369-76. PMID: 16302273.
      View in: PubMed
    35. Garcia JM, Garcia-Touza M, Hijazi RA, Taffet G, Epner D, Mann D, Smith RG, Cunningham GR, Marcelli M. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab. 2005 May; 90(5):2920-6. PMID: 15713718.
      View in: PubMed
    36. Hijazi RA, Cunningham GR. Andropause: is androgen replacement therapy indicated for the aging male? Annu Rev Med. 2005; 56:117-37. PMID: 15660505.
      View in: PubMed
    37. Clarke SC, Reid JA, Thom L, Diggle MA, Mcchlery S, Scott K, Edwards GFS, Mcknight AJ, Shaw A, Goldsmith CE, Clarke L, Millar BC, Mccaughan J, Elborn JE, Reid A, Moore JE, Wu FS, Juan CW, Huang SM, Chang YJ, Chou -L, Siebers R, Mitsuhashi N, Matsuda M, Murayama O, Millar BC, Moore JE, Memish ZA, Balkhy HH, Francis C, Cunningham G, Hajeer AH, Almuneef MA. Biomedical Science in Brief. Br J Biomed Sci. 2005 Jan; 62(1):28-30. PMID: 28696915.
      View in: PubMed
    38. Wang C, Swerdloff R, Kipnes M, Matsumoto AM, Dobs AS, Cunningham G, Katznelson L, Weber TJ, Friedman TC, Snyder P, Levine HL. New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men. J Clin Endocrinol Metab. 2004 Aug; 89(8):3821-9. PMID: 15292312.
      View in: PubMed
    39. Hijazi RA, Betancourt-Albrecht M, Cunningham GR. Gonadal and erectile dysfunction in diabetics. Med Clin North Am. 2004 Jul; 88(4):933-45, xi. PMID: 15308386.
      View in: PubMed
    40. Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004 May; 89(5):2179-84. PMID: 15126539.
      View in: PubMed
    41. Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab. 2004 May; 89(5):2085-98. PMID: 15126525.
      View in: PubMed
    42. Albrecht-Betancourt M, Hijazi RA, Cunningham GR. Androgen replacement in men with hypogonadism and erectile dysfunction. Endocrine. 2004 Mar-Apr; 23(2-3):143-8. PMID: 15146093.
      View in: PubMed
    43. Shao TC, Li H, Eid W, Ittmann M, Unni E, Cunningham GR. In vivo preservation of steroid specificity in CWR22 xenografts having a mutated androgen receptor. Prostate. 2003 Sep 15; 57(1):1-7. PMID: 12886517.
      View in: PubMed
    44. Cunningham GR, Ashton CM, Annegers JF, Souchek J, Klima M, Miles B. Familial aggregation of prostate cancer in African-Americans and white Americans. Prostate. 2003 Sep 1; 56(4):256-62. PMID: 12858353.
      View in: PubMed
    45. Betancourt-Albrecht M, Cunningham GR. Hypogonadism and diabetes. Int J Impot Res. 2003 Aug; 15 Suppl 4:S14-20. PMID: 12934046.
      View in: PubMed
    46. Bhasin S, Singh AB, Mac RP, Carter B, Lee MI, Cunningham GR. Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan. J Androl. 2003 May-Jun; 24(3):299-311. PMID: 12721204.
      View in: PubMed
    47. Guay AT, Spark RF, Bansal S, Cunningham GR, Goodman NF, Nankin HR, Petak SM, Perez JB. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple's problem--2003 update. Endocr Pract. 2003 Jan-Feb; 9(1):77-95. PMID: 12917096.
      View in: PubMed
    48. Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N. Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. Clin Endocrinol (Oxf). 2001 Jun; 54(6):739-50. PMID: 11422108.
      View in: PubMed
    49. Swerdloff RS, Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Longstreth J, Berman N. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab. 2000 Dec; 85(12):4500-10. PMID: 11134099.
      View in: PubMed
    50. Marcelli M, Shao TC, Li X, Yin H, Marani M, Denner L, Teng B, Cunningham GR. Induction of apoptosis in BPH stromal cells by adenoviral-mediated overexpression of caspase-7. J Urol. 2000 Aug; 164(2):518-25. PMID: 10893637.
      View in: PubMed
    51. Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab. 2000 Aug; 85(8):2839-53. PMID: 10946892.
      View in: PubMed
    52. Cunningham GR. The future of andrology. J Androl. 2000 Jan-Feb; 21(1):170. PMID: 10670542.
      View in: PubMed
    53. Marcelli M, Cunningham GR. Hormonal signaling in prostatic hyperplasia and neoplasia. J Clin Endocrinol Metab. 1999 Oct; 84(10):3463-8. PMID: 10522981.
      View in: PubMed
    54. Marcelli M, Cunningham GR, Walkup M, He Z, Sturgis L, Kagan C, Mannucci R, Nicoletti I, Teng B, Denner L. Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: overexpression of caspase-7 as a new gene therapy strategy for prostate cancer. Cancer Res. 1999 Jan 15; 59(2):382-90. PMID: 9927051.
      View in: PubMed
    55. Marcelli M, Cunningham GR, Haidacher SJ, Padayatty SJ, Sturgis L, Kagan C, Denner L. Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP. Cancer Res. 1998 Jan 1; 58(1):76-83. PMID: 9426061.
      View in: PubMed
    56. Hirshkowitz M, Moore CA, O'Connor S, Bellamy M, Cunningham GR. Androgen and sleep-related erections. J Psychosom Res. 1997 Jun; 42(6):541-6. PMID: 9226601.
      View in: PubMed
    57. Padayatty SJ, Marcelli M, Shao TC, Cunningham GR. Lovastatin-induced apoptosis in prostate stromal cells. J Clin Endocrinol Metab. 1997 May; 82(5):1434-9. PMID: 9141529.
      View in: PubMed
    58. Cusi K, Cunningham GR, Comstock JP. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM. Diabetes Care. 1995 Jun; 18(6):843-51. PMID: 7555511.
      View in: PubMed
    59. Cunningham GR, Hirshkowitz M. Inhibition of steroid 5 alpha-reductase with finasteride: sleep-related erections, potency, and libido in healthy men. J Clin Endocrinol Metab. 1995 Jun; 80(6):1934-40. PMID: 7775644.
      View in: PubMed
    60. Shao TC, Marcelli M, Kong A, Cunningham GR. Anti-androgen effects of the aromatase inhibitor, atamestane. J Androl. 1995 Mar-Apr; 16(2):100-7. PMID: 7559139.
      View in: PubMed
    61. Shao TC, Kong A, Cunningham GR. Effects of 4-MAPC, a 5 alpha-reductase inhibitor, and cyproterone acetate on regrowth of the rat ventral prostate. Prostate. 1994 Apr; 24(4):212-20. PMID: 7511803.
      View in: PubMed
    62. Shao TC, Kong A, Marafelia P, Cunningham GR. Effects of finasteride on the rat ventral prostate. J Androl. 1993 Mar-Apr; 14(2):79-86. PMID: 8390428.
      View in: PubMed
    63. Ghusn HF, Shao TC, Klima M, Cunningham GR. 4-MAPC, a 5 alpha-reductase inhibitor, reduces rat ventral prostate weight, DNA, and prostatein concentrations. J Androl. 1991 Sep-Oct; 12(5):315-22. PMID: 1765567.
      View in: PubMed
    64. Assaad SN, Cunningham GR, Samaan NA. Abnormal growth hormone dynamics in chronic liver disease do not depend on severe parenchymal disease. Metabolism. 1990 Apr; 39(4):349-56. PMID: 2182971.
      View in: PubMed
    65. Cunningham GR, Hirshkowitz M, Korenman SG, Karacan I. Testosterone replacement therapy and sleep-related erections in hypogonadal men. J Clin Endocrinol Metab. 1990 Mar; 70(3):792-7. PMID: 2307732.
      View in: PubMed
    66. Shao TC, Kong A, Young C, Chu WH, Tindall DJ, Cunningham GR. Prostatein C3-mRNA: a sensitive marker of androgen-responsiveness in prostate explant cultures. Prostate. 1990; 17(1):41-55. PMID: 2201006.
      View in: PubMed
    67. Cunningham GR, Cordero E, Thornby JI. Testosterone replacement with transdermal therapeutic systems. Physiological serum testosterone and elevated dihydrotestosterone levels. JAMA. 1989 May 5; 261(17):2525-30. PMID: 2704112.
      View in: PubMed
    68. Young CY, Murthy LR, Prescott JL, Johnson MP, Rowley DR, Cunningham GR, Killian CS, Scardino PT, VonEschenbach A, Tindall DJ. Monoclonal antibodies against the androgen receptor: recognition of human and other mammalian androgen receptors. Endocrinology. 1988 Jul; 123(1):601-10. PMID: 2454813.
      View in: PubMed
    69. Shao TC, Kong AY, Cunningham GR. Acid phosphatase activity: a marker of androgen action in prostate explant cultures. Prostate. 1987; 10(1):69-77. PMID: 2950383.
      View in: PubMed
    70. Shao TC, Tindall DJ, Cunningham GR. Age dependency of androgen and estrogen effects on incorporation of (3H)-thymidine by rat prostates in organ culture. Prostate. 1986; 8(4):349-62. PMID: 2940523.
      View in: PubMed
    71. Cunningham GR. Idiopathic post-pubertal LH deficiency. Ann N Y Acad Sci. 1984; 438:497-500. PMID: 6598335.
      View in: PubMed
    72. Tindall DJ, Chang CH, Lobl TJ, Cunningham GR. Androgen antagonists in androgen target tissues. Pharmacol Ther. 1984; 24(3):367-400. PMID: 6205409.
      View in: PubMed
    73. Prinz PN, Weitzman ED, Cunningham GR, Karacan I. Plasma growth hormone during sleep in young and aged men. J Gerontol. 1983 Sep; 38(5):519-24. PMID: 6684135.
      View in: PubMed
    74. Cunningham GR, Lobl TJ, Cockrell C, Shao TC, Tindall DJ. Characterization of steroid binding specificity of the androgen receptor in human foreskin fibroblasts. Steroids. 1983 May; 41(5):617-26. PMID: 6658893.
      View in: PubMed
    75. Cunningham GR, Tindall DJ, Lobl TJ, Campbell JA, Means AR. Steroid structural requirements for high affinity binding to human sex steroid binding protein (SBP). Steroids. 1981 Sep; 38(3):243-62. PMID: 7197818.
      View in: PubMed
    76. Cunningham GR, Silverman VE, Thornby J, Kohler PO. The potential for an androgen male contraceptive. J Clin Endocrinol Metab. 1979 Oct; 49(4):520-6. PMID: 479345.
      View in: PubMed
    77. Cunningham GR, Huckins C. Persistence of complete spermatogenesis in the presence of low intratesticular concentrations of testosterone. Endocrinology. 1979 Jul; 105(1):177-86. PMID: 446406.
      View in: PubMed
    78. Cunningham GR, Tindall DJ, Means AR. Differences in steroid specificity for rat androgen binding protein and the cytoplasmic receptor. Steroids. 1979 Mar; 33(3):261-76. PMID: 442122.
      View in: PubMed
    79. Cunningham GR, Huckins C. Serum FSH, LH, and testosterone in 60Co gamma-irradiated male rats. Radiat Res. 1978 Nov; 76(2):331-8. PMID: 752160.
      View in: PubMed
    80. Nichols ML, Brown RD, Granville GE, Cunningham GR, Tanaka K, Orth DN. Isolated deficiency of adrenocorticotropin (ACTH) and lipotropins (LPHs). J Clin Endocrinol Metab. 1978 Jul; 47(1):84-90. PMID: 233663.
      View in: PubMed
    81. Tindall DJ, Cunningham GR, Means AR. 5alpha-Dihydrotestosterone binding to androgen binding protein. Effects of testosterone and other compounds in vivo and in vitro on the number of binding sites measured. J Biol Chem. 1978 Jan 10; 253(1):166-9. PMID: 618855.
      View in: PubMed
    82. Cunningham GR, Goldzieher JW, de la Pena A, Oliver M. The mechanism of ovulation inhibition by triamcinolone acetonide. J Clin Endocrinol Metab. 1978 Jan; 46(1):8-14. PMID: 376542.
      View in: PubMed
    83. Cunningham GR, Tindall DJ, Huckins C, Means AR. Mechanisms for the testicular hypertrophy which follows hemicastration. Endocrinology. 1978 Jan; 102(1):16-23. PMID: 743944.
      View in: PubMed
    84. Cunningham GR, Huckins C. An FSH and prolactin-secreting pituitary tumor: pituitary dynamics and testicular histology. J Clin Endocrinol Metab. 1977 Feb; 44(2):248-53. PMID: 402377.
      View in: PubMed
    85. Cunningham GR, Caperton EM, Goldzieher JW. Antiovulatory activity of synthetic corticoids. J Clin Endocrinol Metab. 1975 Feb; 40(2):265-7. PMID: 1117979.
      View in: PubMed
    86. Soule TI, Cunningham GR. Herbicola lathyri septicemia, myoglobinuria, and acute renal failure. JAMA. 1973 Mar 12; 223(11):1265-6. PMID: 4739329.
      View in: PubMed
    87. Cunningham GR, Quickel KE, Lebovitz HE. The use of insulin dynamics in the evaluation of streptozotocin therapy of malignant insulinomas. J Clin Endocrinol Metab. 1971 Sep; 33(3):530-6. PMID: 4328341.
      View in: PubMed
    CUNNINGHAM's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _